National Claims
Inactive· since Feb 15, 2026
- 33
- days it ran
- 0
- relaunches
Ad copy
They knew. They sold it anyway. 😠 Multiple studies linked Dupixent to T-cell lymphoma risk. The FDA is now investigating. But for years, the label contained no cancer warning. If you developed lymphoma after taking Dupixent, it's time for answers.
🪄Crush AI
Like this ad? Make it yours.
Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.
